BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
0.9800
-0.0300 (-2.97%)
At close: Mar 31, 2025, 4:00 PM
0.9850
+0.0050 (0.51%)
Pre-market: Apr 1, 2025, 6:22 AM EDT
BioVie Market Cap
BioVie has a market cap or net worth of $18.08 million as of April 1, 2025. Its market cap has decreased by -35.88% in one year.
Market Cap
18.08M
Enterprise Value
-5.94M
1-Year Change
-35.88%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $18.08M, a decrease of -65.23%. That is a compound annual growth rate of -20.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 18.60M | -47.61% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |